Pooled analysis showed a trend towards reduced in-hospital mortality with GDMT use in ACS patients with advanced renal dysfunction, consistent with findings from the overall cohorts (RR: 0.62, 95% CI: 0.45 to 0.86; online supplemental figure S5 ).
← all excerpts
Guideline-directed medical therapy and in-hospital mortality in acute coronary syndrome patients with advanced renal dysfunction: analysis of two nationwide retrospective cohort studies.
1
—
—